Castleview Partners’s JP Morgan Alerian MLP Index ETN 5/24/24 AMJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-877
Closed -$25K 1012
2024
Q1
$25K Hold
877
0.01% 436
2023
Q4
$22.2K Hold
877
0.02% 424
2023
Q3
$21.7K Sell
877
-77
-8% -$1.84K 0.02% 351
2023
Q2
$21.9K Hold
954
0.02% 344
2023
Q1
$21.2K Hold
954
0.02% 344
2022
Q4
$20.7K Hold
954
0.02% 298
2022
Q3
$19K Buy
954
+938
+5,863% +$19.6K 0.02% 326
2022
Q2
$769 Sell
16
-938
-98% -$19.8K ﹤0.01% 706
2022
Q1
$19K Buy
+954
New +$19.2K 0.01% 435

Other funds holding AMJ

Castleview Partners's AMJ Position: Q2 2024 in Review

Castleview Partners sold out of JP Morgan Alerian MLP Index ETN 5/24/24 (AMJ) in Q2 2024, closing a stake of 877 shares — an estimated $25K sold.

Castleview Partners first reported a position in AMJ in Q1 2022 and held it in 9 quarters. The position peaked at $25K in Q1 2024. 2 funds tracked by Wall St. Rank hold AMJ as of Q2 2024.

  • Castleview Partners reported no remaining JP Morgan Alerian MLP Index ETN 5/24/24 position as of Q2 2024 after selling out during the quarter.
  • Castleview Partners sold 877 JP Morgan Alerian MLP Index ETN 5/24/24 shares in Q2 2024, an estimated $25K.
  • Castleview Partners first reported a position in JP Morgan Alerian MLP Index ETN 5/24/24 in Q1 2022 and held it in 9 quarters.
  • Castleview Partners's JP Morgan Alerian MLP Index ETN 5/24/24 position peaked at $25K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held JP Morgan Alerian MLP Index ETN 5/24/24 as of Q2 2024.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.